D
티앤알바이오팹
246710KOSDAQ39.0 / 100
Reference Date: 2026-10-23
Financial Score9.5 / 40
News Sentiment12.5 / 25
Momentum7.0 / 20
Disclosure10.0 / 15
AI Analysis: the high debt ratio poses financial risk, ROE is below the industry average. Declined 10.0% over the past month, with no recent news.
Company InformationBased on 2025 Annual Report
Business Overview
T&N Biofabrication focuses on regenerative medicine, bio-surgical solutions, and cosmetics, leveraging its 3D bioprinting systems, bioinks, and biodegradable scaffolds. The company is developing 3D organoids and cell therapies through long-term R&D while also advancing short-term revenue streams via bio-surgical solutions.
Number of Employees
82people
Average Salary
51.4M KRW
Score Calculation Basis
Detailed Financial Score
PER
—Industry Average 15.004.0Point
PBR
3.70Industry Average 1.200.0Point
3.1x industry avg (risky)
ROE
-127.09Industry Average 8.000.0Point
Well below industry avg
Debt Ratio
202.46Industry Average 100.000.0Point
2.0x industry avg (risky)
Trend 2023~20255.5 / 10 points
Revenue Growth Rate
3.0 / 3
Avg ▲223.5% (2-year basis)
Operating Profit Growth Rate
2.5 / 3
Avg ▲13.7% (2-year basis)
ROE Trend
0.0 / 4
Avg ROE -64.3% (declining, 3yr)
Detailed News Sentiment
0 totalPositive 0Neutral 0Negative 0
Detailed Momentum
52-week position3.0Point
52w lower range (24%)
Current 2,025Won52-week high 4,53552-week low 1,194
1-month return1.0Point
1m -10.00% (falling)
Volume trend3.0Point
Volume flat
Detailed Disclosure
1 totalPositive 0Neutral 1Negative 0
- Neutral연결재무제표기준영업(잠정)실적(공정공시)2026-10-19